Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile.
Mattei JC, Bouvier-Labit C, Barets D, Macagno N, Chocry M, Chibon F, Morando P, Rochwerger RA, Duffaud F, Olschwang S, Salas S, Jiguet-Jiglaire C. Mattei JC, et al. Among authors: jiguet jiglaire c. Cancers (Basel). 2020 Mar 3;12(3):583. doi: 10.3390/cancers12030583. Cancers (Basel). 2020. PMID: 32138169 Free PMC article.
Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening.
Jiguet Jiglaire C, Baeza-Kallee N, Denicolaï E, Barets D, Metellus P, Padovani L, Chinot O, Figarella-Branger D, Fernandez C. Jiguet Jiglaire C, et al. Exp Cell Res. 2014 Feb 15;321(2):99-108. doi: 10.1016/j.yexcr.2013.12.010. Epub 2013 Dec 16. Exp Cell Res. 2014. PMID: 24355810
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.
Jiguet-Jiglaire C, Boissonneau S, Denicolai E, Hein V, Lasseur R, Garcia J, Romain S, Appay R, Graillon T, Mason W, Carpentier AF, Brandes AA, Ouafik L', Wick W, Baaziz A, Gigan JP, Argüello RJ, Figarella-Branger D, Chinot O, Tabouret E. Jiguet-Jiglaire C, et al. Acta Neuropathol Commun. 2022 Jan 3;10(1):1. doi: 10.1186/s40478-021-01305-4. Acta Neuropathol Commun. 2022. PMID: 34980260 Free PMC article.
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.
Chanez B, Appay R, Guille A, Lagarde A, Colin C, Adelaide J, Denicolai E, Jiguet-Jiglaire C, Bequet C, Graillon T, Boissonneau S, Nanni-Metellus I, Dufour H, Figarella-Branger D, Chinot O, Tabouret E. Chanez B, et al. Among authors: jiguet jiglaire c. J Neurol Sci. 2022 May 15;436:120207. doi: 10.1016/j.jns.2022.120207. Epub 2022 Feb 24. J Neurol Sci. 2022. PMID: 35259554
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma.
Joshkon A, Tabouret E, Traboulsi W, Bachelier R, Simoncini S, Roffino S, Jiguet-Jiglaire C, Badran B, Guillet B, Foucault-Bertaud A, Leroyer AS, Dignat-George F, Chinot O, Fayyad-Kazan H, Bardin N, Blot-Chabaud M. Joshkon A, et al. Among authors: jiguet jiglaire c. Acta Neuropathol Commun. 2022 Oct 23;10(1):151. doi: 10.1186/s40478-022-01451-3. Acta Neuropathol Commun. 2022. PMID: 36274147 Free PMC article.
Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status.
Eyraud R, Ayache S, Tsvetkov PO, Kalidindi SS, Baksheeva VE, Boissonneau S, Jiguet-Jiglaire C, Appay R, Nanni-Metellus I, Chinot O, Devred F, Tabouret E. Eyraud R, et al. Among authors: jiguet jiglaire c. Cancers (Basel). 2023 Jan 26;15(3):760. doi: 10.3390/cancers15030760. Cancers (Basel). 2023. PMID: 36765718 Free PMC article.
15 results